Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-26

Clinical Trial Update: Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML) [Phase 1]

View source ↗

Summary

This clinical trial update reports the bioequivalence assessment of azacitidine 300 mg film-coated tablets in adults with acute myeloid leukemia. The study is a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Hikma Pharmaceuticals LLC | Conditions: Acute Myeloid Leukaemia | Phase 1 | Status: COMPLETED